
Medistim ASA
OSE:MEDI

Medistim ASA
Operating Income
Medistim ASA
Operating Income Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
![]() |
Medistim ASA
OSE:MEDI
|
Operating Income
kr127.5m
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
13%
|
|
![]() |
Lifecare AS
OSE:LIFE
|
Operating Income
-kr35.3m
|
CAGR 3-Years
-143%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
N/A
|
|
O
|
Observe Medical ASA
OSE:OBSRV
|
Operating Income
-kr51.3m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
Medistim ASA
Glance View
Medistim ASA engages in the development, manufacturing, and distribution of medical equipment and consumables. The company is headquartered in Oslo, Oslo. The company went IPO on 2004-05-28. The company develops, manufactures and distributes medical devices primarily for cardiac and vascular surgery. The firm provides intra-operative standard control applications designed to verify and document quality during surgery. Its product portfolio comprises systems, such as ultrasound imaging systems VeriQ C and MiraQ, as well as probes, which offer Transit Time Flow Measurement (TTFM). The Company’s activities are divided into four business areas: lease of equipment within cardiac surgery, capital and consumable sales within cardiac surgery, sales of electronic stethoscopes and distribution and sales of third party products. Furthermore, the Company is a parent of Medistim USA Inc, Medistim Deutschland GmbH, and Medistim Norge AS, among others.

See Also
What is Medistim ASA's Operating Income?
Operating Income
127.5m
NOK
Based on the financial report for Sep 30, 2024, Medistim ASA's Operating Income amounts to 127.5m NOK.
What is Medistim ASA's Operating Income growth rate?
Operating Income CAGR 10Y
13%
Over the last year, the Operating Income growth was -12%. The average annual Operating Income growth rates for Medistim ASA have been 2% over the past three years , 5% over the past five years , and 13% over the past ten years .